Center for International Blood & Marrow Transplant Research (CIBMTR)

Center for International Blood & Marrow Transplant Research (CIBMTR) A Research Collaboration Between the Medical College of Wisconsin and NMDP.

CIBMTR is a research collaboration between the Medical College of Wisconsin and NMDP. CIBMTR provides a unique resource of information and expertise to the medical and scientific community. Now with data from more than 630,000 patients, more than 1,750 publications, and approximately 250 ongoing studies and clinical trials, CIBMTR is at the forefront of research to increase access to cellular therapies and to improve outcomes.

Elevate your expertise in transplantation, cell, and gene therapy from discovery to delivery at . Join us in February 2...
11/12/2025

Elevate your expertise in transplantation, cell, and gene therapy from discovery to delivery at . Join us in February 2026 in Salt Lake City to explore breakthroughs, connect with leaders, and move the field forward.

Welcoming 5,000+ attendees from around the world, the Tandem Meetings bring together physicians, researchers, nurses, pharmacists, nurse practitioners, physi...

We’ve had a great few days at the 2025 ISOQOL Conference! Thank you to all who connected with us!
10/26/2025

We’ve had a great few days at the 2025 ISOQOL Conference! Thank you to all who connected with us!

CIBMTR’s patient-reported outcomes team presenting at the CIBMTR-sponsored symposium during this week’s ISOQOL conferenc...
10/24/2025

CIBMTR’s patient-reported outcomes team presenting at the CIBMTR-sponsored symposium during this week’s ISOQOL conference!

10/23/2025

Dive into the latest advancements in research at ! Register today to reserve your spot in Salt Lake City, Feb. 4-7, 2026! View the scientific program:

Getting after an organ transplant may be risky, according to a recent CIBMTR study. Read more about the results of thi...
10/20/2025

Getting after an organ transplant may be risky, according to a recent CIBMTR study. Read more about the results of this study:https://cibmtr.org/Files/Patient-Summaries/Other-Topics-Related-to-Transplant/Late-Effects-and-Quality-of-Life/2025.06.23-Gupta-Accessible.pdf

New Working Committee Co-Scientific Director: Rohtesh Mehta, MD, MPH, MS, to serve as co-Scientific Director of the Immu...
10/16/2025

New Working Committee Co-Scientific Director: Rohtesh Mehta, MD, MPH, MS, to serve as co-Scientific Director of the Immunobiology Working Committee. Read more about this exciting announcement:

Rohtesh Mehta, MD, MPH, MS, will serve as a new co-Scientific Director of the Immunobiology Working Committee.

It gives us great pleasure to announce that Amy Moskop, MD, MS, has been confirmed as the new co-Principal Investigator ...
10/15/2025

It gives us great pleasure to announce that Amy Moskop, MD, MS, has been confirmed as the new co-Principal Investigator (PI) on U24-CA076518: A Data Resource for Blood and Marrow Transplants and Adoptive Cellular Therapy Research. In this role, she will partner with Bronwen Shaw, MD, PhD, on this multiple PI grant. Read more:

It gives us great pleasure to announce that Amy Moskop, MD, MS, has been confirmed as the new co-Principal Investigator (PI) on U24-CA076518: A Data Resource for Blood and Marrow Transplants and Adoptive Cellular Therapy Research.

Address

Medical College Of Wisconsin, Center For Cancer Discovery, 8701 Watertown Plank Road, Suite N1400
Milwaukee, WI
53226

Website

Alerts

Be the first to know and let us send you an email when Center for International Blood & Marrow Transplant Research (CIBMTR) posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Shortcuts

Share

Share on Facebook Share on Twitter Share on LinkedIn
Share on Pinterest Share on Reddit Share via Email
Share on WhatsApp Share on Instagram Share on Telegram

Category

Our Story

The CIBMTR has a broad range of research activities, but our focus is narrow. Patients. They are the reason the CIBMTR exists. Patients count on us to discover and apply the best therapies that research has identified, and to never let up in our efforts to improve those therapies.